Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 40

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 40
---
XERIANT, INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

(UNAUDITED)

INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Condensed Consolidated Balance Sheets as of March 31, 2025 (Unaudited) and June 30, 2024 F-2   Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2025 and 2024 (Unaudited) F-3     Condensed Consolidated Statements of Stockholders’ Deficit for the three and nine months ended March 31, 2025 and 2024 (Unaudited)F-4     Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2025 and 2024 (Unaudited) F-6     Notes to Unaudited Condensed Consolidated Financial Statements F-7

 F-1Table of Contents

XERIANT, INC.  

CONDENSED CONSOLIDATED BALANCE SHEETS 

  As of   As of    March 31, 2025  June 30, 2024   Unaudited    Assets      Current assets      Cash $53,587  $653,117 Prepaids  8,335   2,931 Note receivable  -   8,163 Total current assets  61,922   664,211          Deposits  -   12,546 Property & equipment, net  2,861   3,995 Operating lease right-of-use asset, net  8,389   32,253 Total assets $73,172  $713,005          Liabilities and stockholders’ deficit        Current liabilities        Accounts payable and accrued liabilities $954,928  $1,211,533 Accrued liabilities, related party  4,000   20,000 Shares to be issued  57,000   75,200 Convertible notes payable, net of discount - in default  5,900,000   5,850,000 Convertible notes payable, net of discount  1,740,000   2,132,529